PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
17 hedge funds and large institutions have $11.4M invested in PLx Pharma Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
5% more capital invested
Capital invested by funds: $10.8M → $11.4M (+$579K)
6% less funds holding
Funds holding: 18 → 17 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$2.08M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$763K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$146K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$80.7K |
| 5 |
Renaissance Technologies
New York
|
+$69.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$865K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$515K |
| 3 |
HWA
Heritage Way Advisors
Rockford,
Illinois
|
-$83.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2K |
PLXP Hedge Fund Activity: Q4 2017 in Review
17 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2017, worth a combined $11.4M — up 5.4% from $10.8M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PLXP and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 5 added.
The largest buyer was Harel Insurance Investments & Financial Services, adding an estimated $2.08M. The largest seller was 683 Capital Management, cutting an estimated $865K.
- 17 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2017, down from 18 in Q3 2017.
- Funds reported $11.4M of PLx Pharma Inc. Common Stock stock for Q4 2017, up 5.4% quarter-over-quarter.
- 2 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2017 and 3 closed out, a net change of -1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q4 2017 was Harel Insurance Investments & Financial Services, an estimated $2.08M added.
- The largest PLx Pharma Inc. Common Stock seller in Q4 2017 was 683 Capital Management, an estimated $865K sold.
Based on aggregated 13F filings for Q4 2017.